Certara, a leader in model-informed drug development, announced its participation in three upcoming investor conferences: RBC CM Global Healthcare Conference on May 19, William Blair’s Annual Growth Stock Conference on June 2, and Jefferies Global Healthcare Conference on June 3. The company will webcast its presentations live and provide replays for 90 days, offering investors insights into its business and growth strategy. This engagement reflects Certara's ongoing efforts to communicate its value and progress to the investment community.
Cytokinetics granted stock options for 20,807 shares and 13,793 restricted stock units (RSUs) to eight new employees who started in April and May 2026. The RSUs vest over three years, while the stock options vest over four years with an exercise pric...
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
project44 announced a 34% year-over-year increase in new Annual Recurring Revenue (ARR) for Q1 FY27, fueled by strong adoption of its AI agent portfolio and Intelligent Transportation Management System (TMS). The AI agents automate key logistics task...
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...
